|
BET inhibition and Ovarian Cancer
|
|
Resverlogix Corp.
|
Apr 09, 2021 01:53AM
|
|
BET inhibition and Sepsis - Repeat so it doesn't get lost
|
|
Resverlogix Corp.
|
Apr 09, 2021 12:32AM
|
|
BET Inhibition and Skin Ulcers - I KNEW it!!
|
|
Resverlogix Corp.
|
Apr 09, 2021 01:02PM
|
|
BET inhibition for Dementia and ALS
|
|
Resverlogix Corp.
|
Apr 09, 2021 12:11AM
|
|
BET inhibition in paediatric cancers
|
|
Resverlogix Corp.
|
May 31, 2021 11:53AM
|
|
BETonMACE Prespecified Cognition Assessment Results - Post-CTAD Conference Call - Transcript - 191206
|
7
|
Resverlogix Corp.
|
Dec 08, 2019 10:12AM
|
|
Biopharma products in development for COVID-19
|
1
|
Resverlogix Corp.
|
Sep 03, 2020 05:20PM
|
|
BioWorld mention
|
3
|
Resverlogix Corp.
|
Mar 25, 2021 11:54PM
|
|
BRD4, adenocarcinoma, and overcoming BETi resistance
|
|
Resverlogix Corp.
|
May 31, 2021 11:43AM
|
|
BRD4: An emerging prospective therapeutic target in glioma
|
|
Resverlogix Corp.
|
Apr 02, 2021 04:45AM
|
|
Car-T cell therapy combined with Zen 3694?
|
4
|
Zenith Epigenetics
|
Sep 25, 2017 08:56PM
|
|
CG-13250
|
2
|
Resverlogix Corp.
|
Oct 04, 2017 12:57PM
|
|
Chemical probes targeting epigenetic proteins: Applications beyond oncology
|
4
|
Resverlogix Corp.
|
Aug 04, 2017 10:29PM
|
|
Choline and ApoE4
|
|
Resverlogix Corp.
|
Mar 16, 2021 12:51PM
|
|
Combo BET inhibiton & CDK9 inhibition for melanoma
|
|
Resverlogix Corp.
|
Apr 08, 2021 11:59PM
|
|
Connection issues again
|
|
Resverlogix Corp.
|
Dec 06, 2019 07:33AM
|
|
Couple of marginally relevant articles
|
4
|
Resverlogix Corp.
|
May 26, 2022 01:52AM
|
|
COVID 19 Cardiac Damage - Nature
|
|
Resverlogix Corp.
|
Apr 24, 2021 03:34AM
|
|
Covid and BETonMACE, etc. Rambling.
|
7
|
Resverlogix Corp.
|
Apr 24, 2021 03:25AM
|
|
COVID-19 and BRD4: a stormy and cardiotoxic bromo-romance
|
6
|
Resverlogix Corp.
|
Nov 10, 2021 10:40AM
|
